| View |
|
DRP-15021
|
Sodium Alginate Sodium Bicarbonate + Calcium
Carbonate
|
Tumiwel
|
500mg/213mg/ 325mg per 10 mL
|
Oral Suspension
|
Antacid
|
LifeSquare Laboratories Inc.
|
Philippines
|
Initial [OTC]
|
13 March 2024
|
13 March 2029
|
| View |
|
DRP-15023
|
Lamotrigine
|
Lymogin
|
25 mg
|
Tablet
|
Antiepileptic
|
Globela Pharma Private Limited
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
DRP-15024
|
Lamotrigine
|
Lymogin
|
50 mg
|
Tablet
|
Antiepileptic
|
Globela Pharma Private Limited
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
DRP-15025
|
Lamotrigine
|
Lymogin
|
100 mg
|
Tablet
|
Antiepileptic
|
Globela Pharma Private Limited
|
India
|
Initial
|
13 March 2024
|
13 March 2029
|
| View |
|
HRP-643
|
Povidone-Iodine
|
Poviline 10
|
100 mg/mL (10% w/v)
|
Topical Solution
|
Antiseptic/Disinfectant
|
Nanz Med Science Pharma Pvt. Ltd.
|
India
|
Initial [HR]
|
13 March 2024
|
13 March 2029
|
| View |
|
HRP-642
|
Povidone-Iodine
|
Poviline 7.5
|
75 mg/mL (7.5% w/v)
|
Topical Solution
|
Antiseptic/Disinfectant
|
Nanz Med Science Pharma Pvt. Ltd.
|
India
|
Initial [HR]
|
13 March 2024
|
13 March 2029
|
| View |
|
DRHR-2351
|
Benzalkonium Chloride
|
Ultrasept
|
0.2% w/v
|
Solution
|
Antiseptic/Disinfectant
|
J. Chemie Laboratories, Inc.
|
Philippines
|
Initial [HR]
|
13 March 2024
|
13 March 2026
|
| View |
|
DR- XY49022
|
Sevoflurane
|
Sevotroy 250
|
100% v/v Volatile
|
Liquid for Inhalation.
|
General Anesthetic
|
Troikaa Pharmaceuticals, Ltd.
|
India
|
Initial
|
14 March 2024
|
14 March 2029
|
| View |
|
DRP-15031
|
Benzylpenicillin (as sodium)
|
Inzocillin-5
|
5,000,000 IU (equivalent to 3 g)
|
Powder For Injection (I.M./I.V.)
|
Antibacterial (Beta-lactamase Sensitive Penicillin)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
Initial
|
20 March 2024
|
20 March 2029
|
| View |
|
DRP-15026
|
Vecuronium bromide
|
Sacuron 4
|
4 mg
|
Lyophilized Powder for Injection (IV)
|
Muscle relaxant
|
Sakar Healthcare Limited
|
India
|
Initial
|
18 March 2024
|
18 March 2029
|
| View |
|
DRP-1552-03
|
FURAZOLIDONE
|
Unbranded
|
50 mg/15 mL
|
Suspension
|
Antiprotozoal
|
Lifesquare Laboratories Inc.
|
Philippines
|
Renewal
|
28 May 2024
|
19 June 2026
|
| View |
|
DRP-15027
|
Fluticasone
|
Ticanase
|
50 mcg/actuation (0.05% w/w)
|
Nasal Spray
|
Corticosteroids.
|
European Egyptian Pharmaceutical Industries Co.
|
Egypt
|
Initial
|
19 March 2024
|
19 March 2029
|
| View |
|
DRP-15032
|
Bupivacaine hydrochloride
|
Bupidex
|
5 mg/mL (0.5% w/v)
|
Solution for Intrathecal Injection
|
Local Anesthetic (Amide)
|
Swiss Parenterals Ltd. (Block-B)
|
India
|
Initial
|
20 March 2024
|
20 March 2029
|
| View |
|
DRP-15033
|
Bupivacaine hydrochloride
|
Recaine
|
5 mg/mL (0.5% w/v)
|
Solution for Intrathecal Injection
|
Local Anesthetic (Amide).
|
Reyon Pharmaceuticals Co., Ltd.
|
Korea
|
Initial
|
20 March 2024
|
20 March 2029
|
| View |
|
DRP-15028
|
Multivitamins + Minerals
|
Xanoca Performs
|
Formulation:
Each effervescent tablet contains: Ascorbic Acid 500 mg
Pantothenic Acid (Vitamin B5) (as Calcium Pantothenate) 23 mg Niacinamide (Vitamin B3) 50 mg
Thiamine Hydrochloride (Vitamin B1) 15 mg Riboflavin (Vitamin B2)
(as Riboflavin Sodium Phosphate) 15 mg Pyridoxine Hydrochloride (Vitamin B6) 10 mg
Cyanocobalamin (Vitamin B12) 10 mcg Calcium (as Calcium Carbonate) 100 mg Magnesium (as Magnesium Sulphate anhydrous, Magnesium Carbonate) 100 mg Zinc (as Zinc Monohydrate) 10 mg
Folic Acid 400 mcg
Biotin 150 mcg
|
Effervescent
Tablet (Berry Flavor)
|
Vitamin/Mineral
|
Vovantis Laboratories Private Limited
|
India
|
Initial [OTC]
|
19 March 2024
|
19 March 2029
|
| View |
|
DRP-14965
|
Paracetamol + Phenylphrine HCI + Chlorpheniramine
Maleate
|
Coldmedic Night
|
500 mg/10 mg/4 mg
|
Tablet
|
Antipyretic/Analgesic/Antihistamine/
Nasal Decongestant
|
Medley Pharmaceuticals Limited
|
India
|
Initial [OTC]
|
19 May 2024
|
19 May 2029
|
| View |
|
DR-XY49023
|
Retinol Palmitate (Vitamin A)
|
None
|
100,000 IU
|
Softgel Capsule
|
Vitamins
|
Northfield Laboratories Inc.
|
Philippines
|
Initial
|
21 March 2024
|
21 March 2029
|
| View |
|
DRP-15034
|
Teicoplanin
|
Teiconova-400
|
400 mg
|
Powder for Solution for Injection (IM/IV)
|
Antibacterial (Glycopeptide antibacterial)
|
Dongkook Pharmaceutical Co., Ltd.
|
Korea
|
Initial
|
21 March 2024
|
21 March 2029
|
| View |
|
DRP-15030
|
Co-Amoxiclav
|
Ricoxin
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
|
Baroque Pharmaceuticals Pvt. Ltd.
|
India
|
Initial
|
24 September 2024
|
21 March 2029
|
| View |
|
DRP-15029
|
Adenosine
|
Adenox
|
3 mg/mL (6 mg/2 mL)
|
Solution for I.V. Injection
|
Antiarrhythmic Agent
|
Farbe Firma Pvt. Ltd.
|
India
|
Initial
|
21 March 2024
|
21 March 2029
|